Skip to Main Content


Skip Nav Destination

Abstract PO-007: The Class I/IV HDAC Inhibitor Mocetinostat Augments Anti-Tumor Immune Responses in Melanoma Patients

Cancer Res (2020) 80 (23_Supplement): PO-007.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Elena-Georgiana Dobre
  • Carolina Constantin
  • Marieta Costache
  • Monica Neagu
Journal of Personalized Medicine (2021) 11 (9): 901.
Close Modal

or Create an Account

Close Modal
Close Modal